169 related articles for article (PubMed ID: 32269290)
1. An LCM-based genomic analysis of SPEM, Gastric Cancer and Pyloric Gland Adenoma in an Asian cohort.
Srivastava S; Huang KK; Rebbani K; Das K; Fazreen Z; Yeoh KG; Tan P; Teh M
Mod Pathol; 2020 Oct; 33(10):2075-2086. PubMed ID: 32269290
[TBL] [Abstract][Full Text] [Related]
2. Evidence for heightened genetic instability in precancerous spasmolytic polypeptide expressing gastric glands.
Chen J; Zhu C; Wang C; Hu C; Czajkowsky DM; Guo Y; Liu B; Shao Z
J Med Genet; 2020 Jun; 57(6):385-388. PubMed ID: 30877236
[TBL] [Abstract][Full Text] [Related]
3. Spasmolytic polypeptide-expressing metaplasia (SPEM) cell lineages can be an origin of gastric cancer.
Goldenring JR
J Pathol; 2023 Jun; 260(2):109-111. PubMed ID: 37145865
[TBL] [Abstract][Full Text] [Related]
4. Pyloric gland adenoma: a histologic, immunohistochemical and molecular genetic study of 23 cases.
Chlumská A; Waloschek T; Mukenšnabl P; Martínek P; Kašpírková J; Zámečník M
Cesk Patol; 2015; 51(3):137-43. PubMed ID: 26421956
[TBL] [Abstract][Full Text] [Related]
5. Next-generation sequencing identifies 2 genomically distinct groups among pyloric gland adenomas.
Setia N; Wanjari P; Yassan L; Niu N; Kadri S; Ritterhouse L; Misdraji J; Brown I; Segal J; Hart J
Hum Pathol; 2020 Mar; 97():103-111. PubMed ID: 31783043
[TBL] [Abstract][Full Text] [Related]
6. Pyloric gland adenoma: an entity distinct from gastric foveolar type adenoma.
Chen ZM; Scudiere JR; Abraham SC; Montgomery E
Am J Surg Pathol; 2009 Feb; 33(2):186-93. PubMed ID: 18830123
[TBL] [Abstract][Full Text] [Related]
7. Amphiregulin-deficient mice develop spasmolytic polypeptide expressing metaplasia and intestinal metaplasia.
Nam KT; Lee HJ; Mok H; Romero-Gallo J; Crowe JE; Peek RM; Goldenring JR
Gastroenterology; 2009 Apr; 136(4):1288-96. PubMed ID: 19230855
[TBL] [Abstract][Full Text] [Related]
8. A molecular signature of gastric metaplasia arising in response to acute parietal cell loss.
Nozaki K; Ogawa M; Williams JA; Lafleur BJ; Ng V; Drapkin RI; Mills JC; Konieczny SF; Nomura S; Goldenring JR
Gastroenterology; 2008 Feb; 134(2):511-22. PubMed ID: 18242217
[TBL] [Abstract][Full Text] [Related]
9. Spasmolytic polypeptide-expressing metaplasia (SPEM) associated with gastric cancer in Iceland.
Halldórsdóttir AM; Sigurdardóttrir M; Jónasson JG; Oddsdóttir M; Magnússon J; Lee JR; Goldenring JR
Dig Dis Sci; 2003 Mar; 48(3):431-41. PubMed ID: 12757153
[TBL] [Abstract][Full Text] [Related]
10. On the origin of gastric tumours: analysis of a case with intramucosal gastric carcinoma and oxyntic gland adenoma.
Kumagai K; Shimizu T; Nikaido M; Hirano T; Kakiuchi N; Takeuchi Y; Minamiguchi S; Sakurai T; Teramura M; Utsumi T; Hiramatsu Y; Nakanishi Y; Takai A; Miyamoto S; Ogawa S; Seno H
J Pathol; 2023 Apr; 259(4):362-368. PubMed ID: 36625379
[TBL] [Abstract][Full Text] [Related]
11. Sporadic pyloric gland adenoma associated with a large fundic gland polyp: genetic evidence for stepwise progression.
Nonaka S; Hashimoto T; Oda I; Sekine S
Gastric Cancer; 2020 Nov; 23(6):1102-1106. PubMed ID: 32415517
[TBL] [Abstract][Full Text] [Related]
12. Frequent GNAS and KRAS mutations in pyloric gland adenoma of the stomach and duodenum.
Matsubara A; Sekine S; Kushima R; Ogawa R; Taniguchi H; Tsuda H; Kanai Y
J Pathol; 2013 Mar; 229(4):579-87. PubMed ID: 23208952
[TBL] [Abstract][Full Text] [Related]
13. Trop2 is upregulated in the transition to dysplasia in the metaplastic gastric mucosa.
Riera KM; Jang B; Min J; Roland JT; Yang Q; Fesmire WT; Camilleri-Broet S; Ferri L; Kim WH; Choi E; Goldenring JR
J Pathol; 2020 Jul; 251(3):336-347. PubMed ID: 32432338
[TBL] [Abstract][Full Text] [Related]
14. Decreased expression of TFF2 and decreased αGlcNAc glycosylation are malignant biomarkers of pyloric gland adenoma of the duodenum.
Yamanoi K; Fujii C; Nakayama A; Matsuura N; Takatori Y; Kato M; Yahagi N; Nakayama J
Sci Rep; 2023 Dec; 13(1):21641. PubMed ID: 38062108
[TBL] [Abstract][Full Text] [Related]
15. Decreased expression of gastric gland mucin-specific glycan α1,4-linked N-acetylglucosamine on its scaffold mucin 6 is associated with malignant potential of pyloric gland adenoma of the stomach.
Yamanoi K; Sekine S; Higuchi K; Kushima R; Nakayama J
Histopathology; 2015 Dec; 67(6):898-904. PubMed ID: 25929994
[TBL] [Abstract][Full Text] [Related]
16. Altered expression of a putative progenitor cell marker DCAMKL1 in the rat gastric mucosa in regeneration, metaplasia and dysplasia.
Kikuchi M; Nagata H; Watanabe N; Watanabe H; Tatemichi M; Hibi T
BMC Gastroenterol; 2010 Jun; 10():65. PubMed ID: 20565818
[TBL] [Abstract][Full Text] [Related]
17. [Precursors of gastric cancer : Dysplasia and adenoma].
Langner C
Pathologe; 2017 Mar; 38(2):67-74. PubMed ID: 28229187
[TBL] [Abstract][Full Text] [Related]
18. The clonal origins of dysplasia from intestinal metaplasia in the human stomach.
Gutierrez-Gonzalez L; Graham TA; Rodriguez-Justo M; Leedham SJ; Novelli MR; Gay LJ; Ventayol-Garcia T; Green A; Mitchell I; Stoker DL; Preston SL; Bamba S; Yamada E; Kishi Y; Harrison R; Jankowski JA; Wright NA; McDonald SA
Gastroenterology; 2011 Apr; 140(4):1251-1260.e1-6. PubMed ID: 21223968
[TBL] [Abstract][Full Text] [Related]
19. Initial and crucial genetic events in intestinal-type gastric intramucosal neoplasia.
Rokutan H; Abe H; Nakamura H; Ushiku T; Arakawa E; Hosoda F; Yachida S; Tsuji Y; Fujishiro M; Koike K; Totoki Y; Fukayama M; Shibata T
J Pathol; 2019 Apr; 247(4):494-504. PubMed ID: 30474112
[TBL] [Abstract][Full Text] [Related]
20. Gene expression profiling of metaplastic lineages identifies CDH17 as a prognostic marker in early stage gastric cancer.
Lee HJ; Nam KT; Park HS; Kim MA; Lafleur BJ; Aburatani H; Yang HK; Kim WH; Goldenring JR
Gastroenterology; 2010 Jul; 139(1):213-25.e3. PubMed ID: 20398667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
